Campbell & Co Investment Adviser’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-109,728
Closed -$701K 1133
2025
Q1
$701K Buy
109,728
+49,079
+81% +$473K 0.05% 551
2024
Q4
$721K Buy
+60,649
New +$1.03M 0.06% 523

Other funds holding ASPN

Campbell & Co Investment Adviser's ASPN Position: Q2 2025 in Review

Campbell & Co Investment Adviser sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 109,728 shares — an estimated $701K sold.

Campbell & Co Investment Adviser first reported a position in ASPN in Q4 2024 and held it in 2 quarters. The position peaked at $721K in Q4 2024. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Campbell & Co Investment Adviser reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 109,728 Aspen Aerogels shares in Q2 2025, an estimated $701K.
  • Campbell & Co Investment Adviser first reported a position in Aspen Aerogels in Q4 2024 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's Aspen Aerogels position peaked at $721K in Q4 2024.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.